तुलना करने के लिए मीट्रिक्स | PHR | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत कंस्यूमर नॉन-साइक्लिकल्स | संबंध संबंधPHRपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −13.8x | 1.5x | 12.0x | |
PEG अनुपात | 0.11 | 0.01 | 0.03 | |
क़ीमत/बुक | 3.9x | 1.8x | 1.5x | |
क़ीमत / एलटीएम बिक्री | 24.2x | 1.1x | 0.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 13.7% | 24.9% | |
उचित मूल्य अपसाइड | अनलॉक करें | 16.3% | 13.1% | अनलॉक करें |
Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.